TITLE

Cancer's Achilles' heel

PUB. DATE
December 2007
SOURCE
Marketing Health Services;Winter2007, Vol. 27 Issue 4, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that patients with advanced melanoma who participated in early tests of an experimental drug seemed to show signs of a slowdown in the spreading of the deadly skin cancer. According to Synta Pharmaceuticals Corp., test patients who received the drug survived an average of 3.7 months without new cancer lesions, compared with 1.8 months for those who got the standard treatment. The treatment is given in pill form, but the development of the drug is in such an early stage, it has yet to be named. It must undergo more rigorous testing before the company will seek approval in the United States.
ACCESSION #
28090207

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics